Fabrication Enterprises 00-1361 - Iontopho… | USA MedPremium
Iontophoresis Dose Controller I-Bresis™
USAMP#33441317SKU: 00-1361I-Bresis™
Product Spotlight
I-Bresis hybrid iontophoresis system has the power to deliver optimal drug delivery and flexible, time-saving treatment options
The 3 treatment modes and the ability to deliver medication with positive or negative polarity, allows clinicians to choose the right medication and right application for each patient
I-Bresis Mode powers a 3-minute Skin Conductivity Enhancement to help break down the skin's resistance, resulting in a 40-80mA-min treatment in approximately 1-2 hours
Built-in batteris plus dose controller activation allows quick and effective application
The direct current drives penetration by opening pathways to the skin